Healthcare
The global Healthcare industry is undergoing an era of significant change. The expansion of telemedicine, progress in personalized medicine, and the adoption of advanced diagnostic technologies are rapidly reshaping the market. To remain competitive and capitalize on emerging opportunities, businesses need access to the latest market research and insights.
Frost & Sullivan provides comprehensive market research reports for the Healthcare sector, featuring detailed market forecasts, industry trend analyses, competitive benchmarks, and future growth opportunity assessments. Our reports are crafted by leading industry analysts and researchers, utilizing a thorough research methodology that combines primary and secondary data sources....
Key Topics Covered in Healthcare:
Drug Development & Innovation:
- Rare Disease Treatment Market (Orphan Drugs): Analyzes orphan drugs for rare diseases, including development, regulations, and commercialization.
- Drug Discovery Outsourcing Trends: Explores the growing role of outsourcing in drug discovery and early-phase clinical trials.
- Biotechnology Investment & Funding: Examines trends and opportunities for investment in the biotech sector.
- Innovations in Small Molecule Drug Delivery: Explores advancements in delivering medications to the body more effectively.
Digital Health & Telehealth:
- Digital Mental Health Solutions: Analyzes digital tools used to manage mental health and behavioral conditions.
- Home Care Technology Trends: Explores the use of technology to improve home-based healthcare.
- Mobile Medical Imaging: Analyzes the increasing use of mobile devices for medical imaging.
- Digital Health Regulations: Analyzes regulations impacting the development and use of digital health solutions.
- Healthcare Cloud Services: Examines the adoption of cloud-based IT solutions for healthcare organizations.
Medical Devices & Diagnostics:
- Non-invasive Prenatal Testing: Analyzes the market for prenatal tests that are minimally invasive for the mother.
- Cardiology Medical Imaging Informatics: Explores technologies that manage and analyze heart-specific medical imaging data.
- Hospital-at-Home Platforms & Services: Analyzes services allowing patients to receive hospital-level care at home.
- Digital Pathology Technology Innovations: Explores advancements in using digital tools for analyzing tissue samples.
- Emerging Respiratory Care Companies: Identifies promising companies in the respiratory care space.
- Sports Medicine Industry: Analyzes the market for products and services used in sports medicine.
- Cardiovascular Devices: Analyzes the market for devices used to treat heart conditions.
- Diabetes Care Devices: Analyzes the market for devices used to manage diabetes.
- Molecular Diagnostics for Neurodegenerative Diseases: Analyzes the development and potential of diagnostics for diseases like Alzheimer's and Parkinson's.
- Smartphone-based Point-of-care Testing: Analyzes advancements in using smartphones for medical testing at the point of care.
- Diagnostics Lab Automation & Monitoring Solutions: Explores the market for automated solutions used in diagnostic laboratories.
Other Healthcare Growth Areas:
- Oral Solid Dosage Formulation Industry: Explores opportunities in developing and manufacturing oral medications.
- Direct-to-Consumer Wellness Testing: Examines the growing market for genetic and other wellness tests available directly to consumers.
Clinical Trials & Drug Development Services:
- Growth Opportunities in Drug Discovery and Early Development Outsourcing Services: Analyzes the trend of pharmaceutical companies outsourcing drug discovery and early development activities.
- Innovative AI-enabled Clinical Trial Companies: Identifies and analyzes promising companies using AI in clinical trials.
Biopharmaceutical Products:
- Growth Opportunities in Global Diabetes and Obesity Therapeutics: Analyzes the market for drugs used to treat diabetes and obesity.
- Advances and Growth Opportunities in Ophthalmology Therapeutics (Biologics): Explores advancements and market opportunities for biologic drugs used in treating eye diseases.
For further information on Frost & Sullivan’s research or to speak to one of our team of growth experts about your company’s future growth needs please contact us.
-
14 Jan 2026  |  Global  |  Frost Radar
Frost Radar™: Intelligent Imaging Analysis Systems, 2026
A Benchmarking System to Spark Companies to Action - Innovation That Fuels New Deal Flow and Growth Pipelines
Computed tomography, X-ray radiography, and magnetic resonance imaging have been invaluable tools in disease diagnosis and treatment efficacy assessments, but the practice of manual viewing and grading medical images to identify abnormalities is time-consuming and can delay diagnosis for critical patients. Intelligent imaging analysis systems that...
$4,950.00 -
12 Jan 2026  |  Global  |  Frost Radar
Frost Radar™: Artificial Intelligence-Enabled Clinical Trials, 2026
A Benchmarking System to Spark Companies to Action - Innovation That Fuels New Deal Flow and Growth Pipelines
Artificial intelligence (AI) has been revolutionizing the technology-enabled drug discovery and development landscape. In clinical research, AI has been gaining traction across site selection, trial design and protocol optimization, and patient recruitment and management. Because data is the core discipline of drug development, electronic medical r...
$4,950.00 -
12 Dec 2025  |  Global  |  Frost Radar
Frost Radar: AI-Enabled Drug Discovery, 2025
A Benchmarking System to Spark Companies to Action - Innovation That Fuels New Deal Flow and Growth Pipelines
The discovery of new drug targets for diseases with unmet medical needs has long been hindered by the complexity of processing and interpreting massive volumes of biological data. The increasing volume and veracity of clinical and research data compels the use of enabling tools and technologies, such as cloud computing, AI, machine learning, natura...
$4,950.00 -
02 Dec 2025  |  Global  |  Frost Radar
Frost Radar™: Antibody-Drug Conjugate Contract Development and Manufacturing Organizations, 2025
A Benchmarking System to Spark Companies to Action - Innovation That Fuels New Deal Flow and Growth Pipelines
This Frost Radar™ analyzes the competitive landscape of the antibody-drug conjugate (ADC) contract development and manufacturing organization (CDMO) market. Companies provide the foundational manufacturing and development services for what has become one of the most dynamic and valuable therapeutic modalities in oncology. The success of the ADC rev...
$4,950.00 -
04 Nov 2025  |  North America  |  Frost Radar
Frost Radar™: Revenue Cycle Management Operations in North America, 2025
A Benchmarking System to Spark Companies to Action - Innovation That Fuels New Deal Flow and Growth Pipelines
The revenue cycle management (RCM) operations space is at a structural inflection, and the convergence of technology, regulations, and dynamic buyer expectations is compelling RCM vendors to act and upgrade their value propositions and strategies to remain competitive. Providers have been under significant financial stress in the past few years. Ho...
$4,950.00 -
30 Oct 2025  |  Global  |  Frost Radar
Frost Radar™: Medical Device Connectivity, 2025
A Benchmarking System to Spark Companies to Action - Innovation That Fuels New Deal Flow and Growth Pipelines
Medical device connectivity (MDC) refers to the integration of medical devices across various care settings with health information systems, enabling the seamless exchange of patient data. Connectivity is established through wired (e.g., USB and Ethernet) and wireless (e.g., Wi-Fi and Bluetooth) networks, with the primary goal of minimizing manual ...
$4,950.00 -
24 Oct 2025  |  North America  |  Frost Radar
Frost Radar™: Healthcare Payer-Provider Collaboration Solutions in North America, 2025
A Benchmarking System to Spark Companies to Action - Innovation That Fuels New Deal Flow and Growth Pipelines
This Frost Radar™ analysis investigates the healthcare platforms and tools that enhance communication and collaboration between care providers and payers for services, as well as the interfaces that connect payers and providers directly. The payer is often a private insurer, but could also be a patient or a government entity. As the industry transi...
$4,950.00 -
09 Oct 2025  |  Global  |  Frost Radar
Frost Radar™: Laboratory Automation Systems, 2025
A Benchmarking System to Spark Companies to Action - Innovation That Fuels New Deal Flow and Growth Pipelines
The pathology workforce shortage, accuracy concerns, and uneven distribution of prices and resources remain persistent challenges for the diagnostics sector. Automation, a broad concept encompassing processes and practices that streamline workflows, save time, and manage increasing workloads, has become a key response to these issues. By combining ...
$4,950.00 -
16 Sep 2025  |  Global  |  Frost Radar
Frost Radar™: Pharmaceutical and Biotech Laboratory Information Management Systems, 2025
A Benchmarking System to Spark Companies to Action - Innovation That Fuels New Deal Flow and Growth Pipelines
The laboratory information management systems (LIMS) market is undergoing a rapid transformation as laboratories look to modernize operations, improve compliance, and accelerate decision-making. The pressure to digitize lab workflows and integrate disparate data sources is positioning LIMS as a central enabler of efficiency and innovation across th...
$4,950.00 -
29 Aug 2025  |  Global  |  Frost Radar
Frost Radar™: Robotic Assisted Surgical Devices, 2025
A Benchmarking System to Spark Companies to Action - Innovation That Fuels New Deal Flow and Growth Pipelines
Robotic-assisted surgical devices (RASDs) have transformed surgical practice by enhancing precision, dexterity, and control during complex procedures. Robotic technology helps surgeons in terms of ergonomics, motion scaling, and tremor filtration. Pay-per-use models or leasing options can alleviate concerns about high acquisition and maintenance co...
$4,950.00